Industry Overview - The high IQ gene embryo screening industry is rapidly developing, with many Silicon Valley elites showing an open and enthusiastic attitude towards it. The cost for screening high IQ embryos is around $5,000 [1] - Companies like Genomic Prediction, Nucleus Genomics, and Herasight are providing embryo gene testing services, with costs ranging from $6,000 to $50,000, indicating high demand in the Bay Area [3][4] Key Players - Genomic Prediction is one of the earliest companies to offer embryo gene testing, targeting ultra-high-net-worth individuals who are obsessed with meritocracy [3] - Nucleus Genomics and Herasight are startups that publicly offer gene IQ testing, with Nucleus's cost at approximately $6,000 and Herasight's at $50,000 [3] Ethical Considerations - The pursuit of "quality genes" reflects Silicon Valley's extreme pursuit of elitism, with ongoing debates surrounding assisted reproductive technology and scientific ethics [3] - Current UK laws prohibit parents from selecting embryos based on IQ predictions, highlighting regulatory challenges in the industry [5] Scientific Insights - Research indicates that cognitive ability is related to many components of the human genome, but current models can only explain about 5% to 10% of the correlation, suggesting limitations in gene testing for predicting intelligence [5] - Experts warn that selecting embryos based on high IQ genes may inadvertently lead to choosing embryos with higher risks for negative traits, such as autism spectrum disorders [5]